National Vaccine
Information Center

Your Health. Your Family. Your Choice.
Search Results

From the 1/7/2022 release of VAERS data:

This is VAERS ID 631258

Government Disclaimer on use of this data

Case Details

VAERS ID: 631258 (history)  
Form: Version 1.0  
Age: 11.0  
Sex: Unknown  
Location: Unknown  
Submitted: 2016-04-13
Entered: 2016-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: Other
Symptoms: Encephalitis, Pharyngitis streptococcal
SMQs:, Agranulocytosis (broad), Oropharyngeal infections (narrow), Noninfectious encephalitis (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: FLUVIRIN
Current Illness: Headache
Preexisting Conditions: Asplenia; Spherocytic anaemia
Diagnostic Lab Data:
CDC Split Type: US2016GSK046308

Write-up: This case was reported by a physician and described the occurrence of meningoencephalitis in a 11-year-old patient who received BEXSERO. The patient''s past medical history included asplenia and spherocytosis. Concurrent medical conditions included headache. Concomitant products included FLUVIRIN. On an unknown date, the patient received the 1st dose of BEXSERO. On an unknown date, an unknown time after receiving BEXSERO, the patient experienced meningoencephalitis (serious criteria hospitalization and GSK medically significant) and streptococcal pharyngitis. On an unknown date, the outcome of the meningoencephalitis and streptococcal pharyngitis were unknown. It was unknown if the reporter considered the meningoencephalitis and streptococcal pharyngitis to be related to BEXSERO. Additional details were provided as follows: In July 2014, the patient had undergone splenectomy. The patient had headache prior to vaccination with BEXSERO. The patient experienced aseptic meningoencephalitis and Group A strep pharyngitis. The patient was receiving not any penicillin prophylaxis at the time of reporting. Follow up information was received on 6th April 2016: It was concluded that the symptoms experienced by the patient were very unlikely related to BEXSERO and that the patient should receive the 2nd dose of the vaccine.

New Search

Link To This Search Result:

Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166